Armodafinil promotes wakefulness and activates Fos in rat brain

Pharmacology Biochemistry and Behavior

Volumn 92, Issue 3, 2009, Pages 549-557

  Fiocchi, Elaine M ^a   Lin, Yin Guo ^a   Aimone, Lisa ^a   Gruner, John A ^a   Flood, Dorothy G ^a  

^a CEPHALON INC   (United States)

Author keywords

Armodafinil; Fos; Immediate early gene; Immunohistochemistry; Narcolepsy; Rat; Sleep; Waking

Indexed keywords

ARMODAFINIL; PROTEIN FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG PROTEIN BINDING; MALE; MOTOR ACTIVITY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; SLEEP WAKING CYCLE; WAKEFULNESS;

ANIMALS; BENZHYDRYL COMPOUNDS; BODY TEMPERATURE; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; WAKEFULNESS;

RATTUS;

EID: 62249162169     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.02.006     Document Type: Article

References (37)

1. Abercrombie M. Estimation of nuclear population from microtome sections. Anat Rec 94 (1946) 239-247
2. Bastuji H., and Jouvet M. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog Neuropsychopharmacol Biol Psychiatry 12 (1988) 695-700
3. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98 (1999) 437-451
4. Cirelli C., and Tononi G. On the functional significance of c-fos induction during the sleep-waking cycle. Sleep 23 (2000) 453-469
5. Czeisler C.A., Walsh J.K., Roth T., Hughes R.J., Wright K.P., Kingsbury L., et al. Modafinil for excessive sleepiness associated with shift-work sleep disorder. N Engl J Med 353 (2005) 476-486
6. Dinges D.F., Arora S., Darwish M., and Niebler G.E. Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss. Curr Med Res Opin 22 (2006) 159-167
7. Edgar D.M., and Seidel W.F. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat. J Pharmacol Exp Ther 283 (1997) 757-769
8. Engber T.M., Koury E.J., Dennis S.A., Miller M.S., Contreras P.C., and Bhat R.V. Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil. Neurosci Lett 241 (1998) 95-98
9. España R.A., and Scammell T.E. Sleep neurobiology for the clinician. Sleep 27 (2004) 811-820
10. Gibaldi M., and Perrier D. Pharmacokinetics (1982), New York, Marcel Dekker
11. Harsh J.R., Hayduk R., Rosenberg R., Wesnes K.A., Walsh J.K., Arora S., et al. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Curr Med Res Opin 22 (2006) 761-774
12. Hermant J.F., Rambert F.A., and Duteil J. Awakening properties of modafinil: effect on nocturnal activity in monkeys (Macaca mulatta) after acute and repeated administration. Psychopharmacology 103 (1991) 28-32
13. Hirshkowitz M., Black J.E., Wesnes K., Niebler G., Arora S., and Roth T. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome. Respir Med 101 (2007) 616-627
14. Jones B.E. Arousal systems. Front Biosci 8 (2003) s438-51
15. Kopp C., Petit J.M., Magistretti P., Borbély A.A., and Tobler I. Comparison of the effects of modafinil and sleep deprivation on sleep and cortical EEG spectra in mice. Neuropharmacology 43 (2002) 110-118
16. Lagarde D., and Milhaud C. Electroencephalographic effects of modafinil, an alpha-1-adrenergic psychostimulant, on the sleep of rhesus monkeys. Sleep 13 (1990) 441-448
17. Lin J.S., Roussel B., Akaoka H., Fort P., Debilly G., and Jouvet M. Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res 591 (1992) 319-326
18. Lin J.S., Hou Y., and Jouvet M. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunohistochemistry in the cat. Proc Natl Acad Sci USA 93 (1996) 14128-14133
19. Lu J., Jhou T.C., and Saper C.B. Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter. J Neurosci 26 (2006) 193-202
20. Opp M.R., and Krueger J.M. Anti-interleukin-1 beta reduces sleep and sleep rebound after sleep deprivation in rats. Am J Physiol 266 Pt 2 (1994) R688-695
21. Pack A.I., Black J.E., Schwartz J.R., and Matheson J.K. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med 164 (2001) 1675-1681
22. Panula P., Yang H.Y.T., and Costa E. Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci USA 81 (1984) 2572-2576
23. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 2nd ed (1986), Academic Press, Sydney
24. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 5th ed (2005), Elsevier Academic Press, Amsterdam
25. Pompeiano M., Cirelli C., and Tononi G. Immediate-early genes in spontaneous wakefulness and sleep: expression of c-fos and NGFI-A mRNA and protein. J Sleep Res 3 (1994) 80-96
26. Roth T., Czeisler C.A., Walsh J.K., Wesnes K.A., Williams M., Neibler G.E., et al. Randomized, double-blind, placebo-controlled study of armodafinil for the treatment of excessive sleepiness associated with chronic shift work sleep disorder. Sleep 30 Suppl 1 (2005) s140
27. Roth T., White D., Schmidt-Nowara W., Wesnes K.A., Niebler G., Arora S., et al. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCAP-adherent adults. Clin Ther 28 (2006) 689-706
28. Sagar S.M., Sharp F.R., and Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240 (1988) 1328-1331
29. Scammell T.E., Estabrooke I.V., McCarthy M.T., Chemelli R.M., Yanagisawa M., Miller M.S., et al. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 20 (2000) 8620-8628
30. Semba K., Pastorius J., Wilkinson M., and Rusak B. Sleep deprivation-induced c-fos and junB expression in the rat brain: effects of duration and timing. Behav Brain Res 120 (2001) 75-86
31. Shelton J., Nishino S., Vaught J., Dement W.C., and Mignot E. Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs. Sleep 18 (1995) 817-826
32. Touret M., Sallanon-Moulin M., and Jouvet M. Awakening properties of modafinil without paradoxical sleep rebound: comparative study with amphetamine in the rat. Neurosci Lett 189 (1995) 43-46
33. US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 43 (1998) 88-97
34. US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology 54 (2000) 1166-1175
35. Vogt B.A., Vogt L., and Farber N.B. Cingulate cortex and disease models. In: Paxinos G. (Ed). The rat nervous system. 3rd ed (2004), Elsevier Academic Press, Amsterdam 705-727
36. Willie J.T., Renthal W., Chemelli R.M., Miller M.S., Scammell T.E., Yanagisawa M., et al. Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates. Neuroscience 130 (2005) 983-995
37. Wisor J.P., Dement W.C., Aimone L., Williams M., and Bozyczko-Coyne D. Armodafinil, the R-enantiomer of modafinil: wake-promoting effects and pharmacokinetic profile in the rat. Pharmacol Biochem Behav 85 (2006) 492-499